Scientists use scorpion venom to cure cancer

Image
Press Trust of India Beijing
Last Updated : Jan 20 2013 | 6:57 AM IST

The homeopathic drug from the venom of the blue scorpion (Rhopalurus junceus), an endemic species in the western part of Cuba, can be used to treat a wide range of cancers such as those of the breast, liver, brain, prostate and lung, according to an annual symposium held in Cuba.

The symposium showcased the study of Cuban researchers into scorpion venom with a new drug called Vidatox 30 CH, state-run Xinhua news agency reported.

Vidatox, produced by Cuba's Entrepreneurial Group for Bio-Pharmaceutical and Chemical Productions (Labiofam), can help increase survival rates of cancer patients, prevent the spread of cancerous cells and improve the quality of life, the report said.

Cancer has been the second leading cause of death in Cuba among all age groups for more than four decades. About 18,000 people die of cancer in Cuba every year, according to official figures.

More than 27,000 cases of cancer are diagnosed each year, the official daily Juventud Rebelde (Rebel Youth) cited Sunday Dr Moses Santos, a specialist in internal medicine, as saying.

The disease has become the leading cause of death among children aged 5 to 10, oncologist Dr Jorge Alvarez said.

Cuba also markets four cancer vaccines to combat the disease, which are developed by the Havana Center for Molecular Immunology (CIM) and exports them to 26 countries in Latin America, Asia and Africa.

The vaccines are divided into "supportive drugs" used to reduce the harmful effects of radiation and chemotherapy, and "specific drugs" designed to fight tumours.

  

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 24 2012 | 4:35 PM IST

Next Story